World's Best Scientists 2026 revealed!
Multiple Sclerosis and Related Disorders
H-index 42

Multiple Sclerosis and Related Disorders

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 382 234 774 40

Additional Metrics

Number of Best Scientists*: 601
Documents by Best Scientists*: 1186
Top 100 Ranked Scientists*: 18
SCIMAGO H-index: 70
SCIMAGO SJR: 1.05
Impact Factor: 2.9

Overview

Top Research Topics at Multiple sclerosis and related disorders?

Multiple sclerosis and related disorders tackles a plethora of topics, such as Multiple sclerosis, Internal medicine, Disease, Pediatrics and Immunology. While Multiple sclerosis is the focus of it, it also provided insights into the studies of Physical therapy and Pathology. The study on Physical therapy presented in it intersects with the topics under Quality of life.

Multiple sclerosis and related disorders focused on Quality of life research but expanded to cover Depression (differential diagnoses). The work on Pathology addressed in it expands to the thematically related Magnetic resonance imaging. Gastroenterology, Fingolimod and Oncology are some topics wherein Internal medicine research discussed in Multiple sclerosis and related disorders have an impact.

Multiple sclerosis and related disorders is focused mainly on Immunology, particularly Antibody. It explores issues in Neuromyelitis optica which can be linked to other research areas like Transverse myelitis, Spectrum disorder, Myelitis and Optic neuritis.

  • Multiple sclerosis (83.05%)
  • Internal medicine (27.16%)
  • Disease (15.67%)

What are the most cited papers published in the journal?

  • Is it time to target no evident disease activity (NEDA) in multiple sclerosis (200 citations)
  • Multiple Sclerosis and Related Disorders (197 citations)
  • Treatment of neuromyelitis optica: Review and recommendations (176 citations)

Research areas of the most cited articles at Multiple sclerosis and related disorders:

The published articles are mainly concerned with subjects like Multiple sclerosis, Internal medicine, Physical therapy, Disease and Immunology. The most cited publications with studies in Multiple sclerosis featured incorporate elements of Surgery, Cognition and Pediatrics. The journal papers hold forums on Internal medicine that merge themes from other disciplines such as Gastroenterology, Placebo and Fingolimod.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Surgery

The previous edition focused in particular on these issues:

The journal is organized to address concerns in the fields of Multiple sclerosis, Internal medicine, Disease, Cohort and Pediatrics. The Multiple sclerosis study featured falls within the larger field of Immunology. Internal medicine research featured in it incorporates concerns from various other topics such as Gastroenterology, Fingolimod and Oncology.

The tackled Disease research is interrelated with Epidemiology which concerns subjects like Demography and Incidence (epidemiology). The featured Neuromyelitis optica studies mainly concentrate on Optic neuritis but also cover areas of interest in Transverse myelitis. In Multiple sclerosis and related disorders, Vaccination and 2019-20 coronavirus outbreak are investigated in conjunction with one another to address concerns in Coronavirus disease 2019 (COVID-19) research.

The most cited articles from the last journal are:

  • Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States. (27 citations)
  • COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review. (22 citations)
  • COVID-19 in ocrelizumab-treated people with multiple sclerosis. (20 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Multiple sclerosis and related disorders (based on the number of publications) are:

  • Gavin Giovannoni (101 papers) published 15 papers at the last edition, 5 less than at the previous edition,
  • Mohammad Ali Sahraian (53 papers) published 11 papers at the last edition, 11 less than at the previous edition,
  • Abdorreza Naser Moghadasi (53 papers) published 8 papers at the last edition, 8 less than at the previous edition,
  • Michael J. Levy (49 papers) published 10 papers at the last edition, 3 less than at the previous edition,
  • Emmanuelle Waubant (47 papers) published 2 papers at the last edition, 9 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Multiple sclerosis and related disorders (based on the number of publications) are:

  • Queen Mary University of London (92 papers) published 16 papers at the last edition, 1 more than at the previous edition,
  • Tehran University of Medical Sciences (78 papers) published 19 papers at the last edition, 2 less than at the previous edition,
  • University of Alabama at Birmingham (58 papers) published 8 papers at the last edition, 6 less than at the previous edition,
  • Harvard University (52 papers) published 12 papers at the last edition, 1 less than at the previous edition,
  • Cleveland Clinic (50 papers) published 7 papers at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 10.62% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 16.43% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.17% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.61% of all publications and 59.79% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Education and Professional Development Opportunities for Research in Multiple Sclerosis and Related Disorders

For all the individuals interested in participating in research projects revolving around Multiple Sclerosis and related disorders, it's instrumental to realize the significance of comprehensive education and professional development. This often begins on the academic level, where students can seek specialized programs and courses that directly correlate with their preferred field of study. For instance, individuals with a healthcare orientation might consider enrolling in Licensed Practical Nurse (LPN) programs. These serve as an excellent foundation for engaging in medical and healthcare research topics, including the study of Multiple Sclerosis and related disorders. Take, for example, the online LPN programs Michigan offers. Such programs provide adequate preparation for students keen on adding value to the healthcare industry, precisely through participation in current and future research undertakings associated with diseases like Multiple Sclerosis and related disorders. The successful completion of these programs imbues students with the necessary expertise and practical knowledge integral to the healthcare industry. Consequently, these students are in a position not only to contribute significantly to research advances but also to lead innovative studies and initiatives aimed at enhancing the wellbeing of individuals diagnosed with Multiple Sclerosis and related disorders. Therefore, a dedicated section to encourage students and researchers to pursue such educational and professional development opportunities is indispensable in articles of this nature.

Top Publications

  • The COVID-19 pandemic and the use of MS disease-modifying therapies.

    Gavin Giovannoni;Chris Hawkes;Jeannette Lechner-Scott;Michael Levy

    (2020)
    185 Citations
  • Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

    Daniel H. Whittam;Daniel H. Whittam;Alvaro Cobo-Calvo;A. Sebastian Lopez-Chiriboga;Santiago Pardo

    (2020)
    159 Citations
  • Effects of MS disease-modifying therapies on responses to vaccinations: A review.

    John Robert Ciotti;Manouela V. Valtcheva;Anne Haney Cross

    (2020)
    136 Citations
  • A case of possible atypical demyelinating event of the central nervous system following COVID-19.

    Anahita Zoghi;Mahtab Ramezani;Mehrdad Roozbeh;Ilad Alavi Darazam

    (2020)
    122 Citations
  • The multiple sclerosis gut microbiota: A systematic review.

    Ali Mirza;Jessica D. Forbes;Feng Zhu;Charles N. Bernstein

    (2020)
    117 Citations
  • Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment.

    Afshin Borhani-Haghighi;Bahareh Kardeh;Shubhasree Banerjee;Golnaz Yadollahikhales

    (2020)
    94 Citations
  • OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.

    (2022)
    88 Citations
  • The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.

    David Baker;Sandra Amor;Sandra Amor;Angray S. Kang;Klaus Schmierer

    (2020)
    84 Citations
  • Long COVID or post COVID-19 syndrome.

    J Lechner-Scott;M Levy;C Hawkes;A Yeh

    (2021)
    81 Citations
  • COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review.

    Maryam Sharifian-Dorche;Maryam Sharifian-Dorche;Mohammad Ali Sahraian;Giulia Fadda;Michael Osherov

    (2021)
    80 Citations

Related Online Degrees & Career Pathways

For those interested in the broader medical field beyond becoming a doctor, several related online degrees offer promising career opportunities. For example, accelerated nursing programs for non nurses provide a fast track for individuals without a nursing background to enter this in-demand profession. These programs are designed to equip students with essential clinical skills efficiently.

Registered nurses looking to advance their qualifications can explore rn to bsn 6 months programs, which offer a convenient and accelerated path to earning a Bachelor of Science in Nursing degree. This can significantly enhance career prospects and open doors to specialized roles.

Becoming a nurse practitioner is another attractive option, known for its blend of clinical practice and patient care autonomy. Understanding how many years does it take to be a nurse practitioner can help prospective students plan their education timelines effectively, as program lengths vary based on the specialty and educational route.

Career outcomes also differ by region; for instance, psychiatric nurse practitioner salary by state data reveals variations that can influence job decisions. Exploring these salary differences helps new graduates and experienced nurses alike make informed choices about their career paths and locations.

Best Scientists Contributing to This Journal

Recently Published Articles